Compare Avalon Labs (AVL) vs Immunefi (IMU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Avalon Labs vs Immunefi — how do they compare? Avalon Labs trades at Rp398.99 (market cap Rp66,23M, Rp100,12M 24h volume), while Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume). The key difference: Avalon Labs is far larger — about 2.5× Immunefi's market cap, and Avalon Labs's circulating supply is 161,7M / 1B AVL (17%) versus 873,4M / 10B IMU (9%) for Immunefi. Which is the better fit depends on your goals — on Pluang, investors hold Avalon Labs for 8 Days and Immunefi for 5 Days on average.
| AVL | IMU | |
|---|---|---|
Market Cap | Rp66,23M | Rp27,03M |
Volume (24h) | Rp100,12M | Rp39,91M |
Circulating Supply | 161,7M / 1B AVL (17%) | 873,4M / 10B IMU (9%) |
Typical Hold Time | 8 Days | 5 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AVL trades at Rp392.75 with a bearish technical signal, showing selling pressure in moving averages but neutral oscillators. The token hovers near support at Rp393, with resistance at Rp409. Market cap is Rp66.43M with 17% of max supply circulating. Recent news lacks crypto-specific updates, focusing incorrectly on corporate activities.
Outlook remains cautious due to weak technicals and low liquidity. Key risks include high volatility and limited adoption. Opportunities exist if the project gains ecosystem traction, but current fundamentals show no significant developments for token holders.
Immunefi token shows limited market activity with a modest market cap of Rp27,03M and low circulation rate of 9%. The asset demonstrates minimal trading volume and network engagement, with token holders maintaining short 5-day holding periods. Recent coverage appears misaligned with the cryptocurrency's actual blockchain metrics, suggesting potential entity confusion.
Outlook remains cautious due to low liquidity and limited ecosystem development. Key opportunities include potential network growth, while major risks involve low adoption, regulatory uncertainty, and market volatility. Investors should monitor on-chain metrics for signs of genuine protocol activity.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Avalon Labs
Avalon Labs is building an on-chain financial center for Bitcoin, offering solutions like BTC-backed lending, a Bitcoin-backed stablecoin, yield-generating accounts, and a credit card. Our goal is to create a scalable, transparent, and accessible financial network for Bitcoin holders to use Bitcoin as an economic asset. AVL is the governance token of the Avalon Labs ecosystem. We started as the world's largest issuer of Bitcoin-backed collateralized debt positions (CDPs) and have since expanded into DeFi lending, fixed-rate CeDeFi models, and stablecoins. This growth, driven by community demand, positions Avalon as a leader in on-chain finance. With AVL, we empower our community to actively shape the future of Avalon.
Read more on AVL →About Immunefi
Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.
Read more on IMU →
